跳至主要内容
临床试验/NCT00165243
NCT00165243已完成2 期

Tangential Radiation Therapy Without Axillary Dissection in Early-Stage Breast Cancer

Dana-Farber Cancer Institute4 个研究点 分布在 1 个国家目标入组 100 人开始时间: 1998年9月最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
入组人数
100
试验地点
4
主要终点
To determine if patients with early-stage breast tumors can be effectively treated by tangential breast radiation.

研究概览

简要总结

The purpose of this study is to evaluate whether treatment to the axilla (area under the arm) can be safely minimized by omitting axillary surgery and full axillary radiation therapy and replacing it with radiation therapy to the breast and lower axilla.

详细描述

  • Patients will have undergone conservative breast surgery without axillary dissection prior to enrollment in this study.
  • Patients will receive radiation therapy to the breast, including the lowest axillary lymph nodes, over a period of 6 1/2 weeks.
  • No radiation will be specifically directed toward the upper axilla or supraclavicular lymph nodes.
  • Patients will also receive 5 years of tamoxifen or another type of hormone therapy determined by the medical oncologist.
  • Follow-up visits will occur every 6 months and mammograms every 12 months.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients must have clinical stage I or II breast cancer, clinically uninvolved axillary nodes.
  • Patients must be 55 years or older.
  • Patients must undergo total excision of the primary invasive tumor
  • Final pathologic margin status must be negative
  • Only estrogen receptor (ER) or progesterone receptor (PR) positive tumors will be permitted

排除标准

  • Prior history of malignancy, except for non-melanoma skin cancers and carcinoma in situ fo the cervix

结局指标

主要结局

To determine if patients with early-stage breast tumors can be effectively treated by tangential breast radiation.

时间窗: 5 years

次要结局

  • To determine the safety of this treatment.(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Julia S. Wong, MD

Principal Investigator

Dana-Farber Cancer Institute

研究点 (4)

Loading locations...

相似试验